Jia Ma

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

End Stage Renal Disease

Ejection Fraction

Ischemia Reperfusion Injury

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Chen, Yue Wang, Xingna Dai, Jingjing Luo, Shangshang Hu, Zhihui Zhou, Jinglong Shi, Xueshan Pan, Tong Cao, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell death & disease 15 (1) (2024)
Kai Chen, Yue Wang, Xingna Dai, Jingjing Luo, Shangshang Hu, Zhihui Zhou, Jinglong Shi, Xueshan Pan, Tong Cao, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell death & disease 15 (1) (2024)
Kai Chen, Yue Wang, Xingna Dai, Jingjing Luo, Shangshang Hu, Zhihui Zhou, Jinglong Shi, Xueshan Pan, Tong Cao, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell death & disease 15 (1) (2024)
Kai Chen, Yue Wang, Xingna Dai, Jingjing Luo, Shangshang Hu, Zhihui Zhou, Jinglong Shi, Xueshan Pan, Tong Cao, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell death & disease 15 (1) (2024)
Kai Chen, Yue Wang, Xingna Dai, Jingjing Luo, Shangshang Hu, Zhihui Zhou, Jinglong Shi, Xueshan Pan, Tong Cao, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell death & disease 15 (1) (2024)
Qi Wang, Linhui Wu, Ruoxue Cao, Jing Gao, Damin Chai, Yanzi Qin, Li Ma, Shiwu Wu, Yisheng Tao, Jia Ma, Zhiwei Peter Wang
Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene 41 (43) (2022)
Linhui Wu, Ke Yu, Kai Chen, Xuelian Zhu, Zheng Yang, Qi Wang, Junjie Gao, Yingying Wang, Tong Cao, Hui Xu, Xueshan Pan, Lixia Wang, Jun Xia, Yuyun Li, Zhiwei Peter Wang, Jia Ma
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell death & disease 13 (3) (2022)